Who Paid My Doc
Redapt
Device Recon Hips
PDI 00885556657850
General payments
$5,386,716
Research payments
$451,694
Through program year 2025, $5,386,716 in general payments and $451,694 in research payments were reported against Redapt (Recon Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $669,017 | 1,232 |
| 2025 | Research | $104,778 | 42 |
| 2024 | General | $908,193 | 984 |
| 2024 | Research | $59,034 | 7 |
| 2023 | General | $1,562,567 | 1,238 |
| 2023 | Research | $185,696 | 15 |
| 2022 | General | $1,457,288 | 1,530 |
| 2022 | Research | $67,633 | 9 |
| 2021 | General | $789,650 | 678 |
| 2021 | Research | $34,553 | 8 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,662 general · 81 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.